Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in diabetic neuropathy
NCT00861042Phase 2Completed
- Sponsor
- UCB
- Start
- Apr 2002
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of lacosamide in diabetic neuropathy, sponsored by UCB. Primary endpoints: Tolerability and safety of long-term SPM 927 administration, Adverse events reported spontaneously or observed and 3 more. Started Apr 2002; status: completed.
02
Drugs
lacosamide
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00861042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861042.